Hyloris Pharmaceuticals SA
LSE:0AB6
Hyloris Pharmaceuticals SA
LSE:0AB6
Price:
6.26
EUR
-7.12%
Market Closed
Market Cap:
€1.7m
Wall Street
Price Targets
0AB6 Price Targets Summary
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA
Wall Street analysts forecast 0AB6 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
0AB6
is 13.84 EUR
with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.
Lowest
Price Target
6.06
EUR
3% Downside
Average
Price Target
13.84
EUR
121% Upside
Highest
Price Target
21.42
EUR
242% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 0AB6's stock price target?
Price Target
13.84
EUR
13.84
EUR
According to Wall Street analysts, the average 1-year price target for
0AB6
is 13.84 EUR
with a low forecast of 6.06 EUR and a high forecast of 21.42 EUR.
What is Hyloris Pharmaceuticals SA's Revenue forecast?
Projected CAGR
110%
110%
For the last 6 years the
compound annual growth rate for
Hyloris Pharmaceuticals SA's revenue is
113%.
The projected
CAGR
for the next 3 years is
110%.
